-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Minerva Neurosciences with Market Outperform Rating, Announces Price Target of $14

Benzinga·04/15/2026 13:18:58
Listen to the news
Citizens analyst Jason N. Butler initiates coverage on Minerva Neurosciences (NASDAQ:NERV) with a Market Outperform rating and announces Price Target of $14.